The challenge of approving add-on therapies for patients with metastatic cancer
5 Jul 2017
The challenge of approving add-on therapies for patients with metastatic cancer
Molecular medicine in lung cancer
Biomarker research in breast cancer
New biomarkers for response to immunotherapy
Current and future immune approaches in precision medicine
Precision medicine enabled histology agnostic development of immunotherapeutics
Incorporating liquid biopsies into clinical trials
Big data, scientific wellness and transforming healthcare
Redesigning clinical trials in the era of precision medicine
Genomic-driven clinical studies in breast cancer
Genomic predictors of treatment response in prostate cancer
Synthetic lethality as a basis to select drug combinations